1. Surgical Principles in the Management of Lung Neuroendocrine Tumors: Open Questions and Controversial Technical Issues

   • Debora Brascia
   • Giuseppe Marulli

   Neuroendocrine Cancers (M Cives, Section Editor) Open access 21 October 2022 Pages: 1645 - 1663

   

2. Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance

   • Fedor Moiseenko
   • Alexey Bogdanov
   • Vladimir Moiseyenko

   Lung Cancer (TA Leal and N Sethakorn, Section Editors) 21 October 2022 Pages: 1664 - 1698

   

3. Targeting KRASp.G12C Mutation in Advanced Non-Small Cell Lung Cancer: a New Era Has Begun

   • Maristella Bungaro
   • Silvia Novello
   • Francesco Passiglia

   Lung Cancer (TA Leal and N Sethakorn, Section Editors) 17 November 2022 Pages: 1699 - 1720

4. Adjuvant Immunotherapy in Patients with Early-Stage Non-small Cell Lung Cancer and Future Directions

   • Stephanie PL Saw
   • Mei-Kim Ang
   • Daniel SW Tan

   Lung Cancer (TA Leal and N Sethakorn, Section Editors) 01 December 2022 Pages: 1721 - 1731

5. Understanding Cancer Cachexia and Its Implications in Upper Gastrointestinal Cancers

   • Leo R. Brown
   • Barry J. A. Laird
   • Richard J. E. Skipworth

   Upper Gastrointestinal Cancers (JD Berlin, Section Editor) Open access 21 October 2022 Pages: 1732 - 1747

   

6. Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus

   • Midhun Malla
   • Jacob Fuqua
   • Richard M. Goldberg

   Upper Gastrointestinal Cancers (JD Berlin, Section Editor) 22 October 2022 Pages: 1748 - 1760

   

7. Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis

   • Kayla M. Daniell
   • Kara Micah Banson
   • Shirin Sioshansi

   Upper Gastrointestinal Cancers (JD Berlin, Section Editor) Open access 05 November 2022 Pages: 1761 - 1774

8. Correction to: Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis

   • Kayla M. Daniell
   • Kara Micah Banson
   • Shirin Sioshansi

   Correction Open access 25 November 2022 Pages: 1775 - 1776

9. Cancer Immunotherapy: Fecal Microbiota Transplantation Brings Light

   • Jie Zhang
   • Kanghui Wu
   • Guangming Li

   Lower Gastrointestinal Cancers (AB Benson, Section Editor) 24 October 2022 Pages: 1777 - 1792

   

10. Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities

    • Carrie Lenneman
    • David Harrison
    • Lavanya Kondapalli

    Cardio-oncology (MG Fradley, Section Editor) 22 November 2022 Pages: 1793 - 1803

    

11. Targeted Therapies in the Treatment of Uterine Serous Carcinoma

    • Joan R. Tymon-Rosario
    • Megan Gorman
    • Alessandro D. Santin

    Gynecologic Cancers (JS Ferriss, Section Editor) 30 November 2022 Pages: 1804 - 1817

12. Contemporary Use of Hormonal Therapy in Endometrial Cancer: a Literature Review

    • Aparna Kailasam
    • Carrie Langstraat

    Gynecologic Cancers (JS Ferriss, Section Editor) 22 November 2022 Pages: 1818 - 1828

    

13. Central Nervous System Prophylaxis and Treatment in Acute Leukemias

    • Susan Y. Wu
    • Nicholas J. Short
    • Penny Q. Fang

    Leukemia (PH Wiernik, Section Editor) Open access 13 December 2022 Pages: 1829 - 1844

    

14. Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy

    • Shannon P. Fortin Ensign
    • Charles Gaulin
    • Maciej M. Mrugala

    Neuro-oncology (GJ Lesser, Section Editor) 16 December 2022 Pages: 1845 - 1860

    

15. Combinations of Chemotherapy and PD-1/PD-L1 Inhibitors in Sarcoma

    • Meghan M. Lynch
    • Borislav A. Alexiev
    • Seth M. Pollack

    Sarcoma (SH Okuno, Section Editor) 16 November 2022 Pages: 1861 - 1876

16. Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies

    • Jingqin Zhong
    • Wangjun Yan
    • Yong Chen

    Correction Open access 02 December 2022 Pages: 1877 - 1878